Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the Company has finalized the planned Praluent® (alirocumab) restructuring with Sanofi. Regeneron also announced important changes ...
The International Ethics Standards Board for Accountants has finished the first phase of its project for restructuring the Code of Ethics for Professional Accountants and has issued some new proposals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback